Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study
NCT01148329
Promus - Registry Experience at the Washington Hospital Center, Drug-eluting Stent (DES)
NCT01003795
DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity
NCT02175706
Evaluation of Effectiveness and Safety of PROMUS Element Stent (IRIS-ELEMENT )
NCT01350791
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
NCT01498692
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cypher
100 patients who have received a Cypher stent during their coronary intervention
No interventions assigned to this group
Taxus Express
100 patients who have received a Taxus Express stent during their coronary intervention
No interventions assigned to this group
Endeavor
100 patients who have received an Endeavor stent during their coronary intervention
No interventions assigned to this group
Promus/Xience V
100 patients who have received a Promus/Xience V stent during their coronary intervention
No interventions assigned to this group
Promus Element
100 patients who have received a Taxus Element stent during their coronary intervention
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with de-novo coronary lesions and slated to receive a Promus Element stent;
* Patients who are slated to undergo IVUS after stent deployment during implantation procedure
Exclusion Criteria
* Patients with in-stent restenosis;
* Patients who had IVUS imaging attained with manual pullback.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medstar Health Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ron Waksman, MD
Role: PRINCIPAL_INVESTIGATOR
Medstar Health Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REWARDS PE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.